Showing Form 4 filings for ETRA
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Electra Therapeutics, Inc.
Price
$7.63
Shares
472,571
Ownership
2,136,979
Value/Share
Gordon Carl L
Dir, 10%
Unknown
Industry
Orbimed Advisors LLC
$15.00
1,333,333
1,758,279